These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
401 related articles for article (PubMed ID: 26546085)
21. Rates of diabetic ketoacidosis: international comparison with 49,859 pediatric patients with type 1 diabetes from England, Wales, the U.S., Austria, and Germany. Maahs DM; Hermann JM; Holman N; Foster NC; Kapellen TM; Allgrove J; Schatz DA; Hofer SE; Campbell F; Steigleder-Schweiger C; Beck RW; Warner JT; Holl RW; Diabetes Care; 2015 Oct; 38(10):1876-82. PubMed ID: 26283737 [TBL] [Abstract][Full Text] [Related]
22. Long-term study of tubeless insulin pump therapy compared to multiple daily injections in youth with type 1 diabetes: Data from the German/Austrian DPV registry. Danne T; Schwandt A; Biester T; Heidtmann B; Rami-Merhar B; Haberland H; Müther S; Khodaverdi S; Haak T; Holl RW; Pediatr Diabetes; 2018 Aug; 19(5):979-984. PubMed ID: 29446511 [TBL] [Abstract][Full Text] [Related]
23. Proportion of Basal to Total Insulin Dose Is Associated with Metabolic Control, Body Mass Index, and Treatment Modality in Children with Type 1 Diabetes-A Cross-Sectional Study with Data from the International SWEET Registry. Rasmussen VF; Vestergaard ET; Schwandt A; Beltrand J; Rami-Merhar B; O'Riordan SMP; Jarosz-Chobot P; Castro-Correia C; Gevers EF; Birkebæk NH J Pediatr; 2019 Dec; 215():216-222.e1. PubMed ID: 31345576 [TBL] [Abstract][Full Text] [Related]
24. HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment. Scott ES; McGrath RT; Januszewski AS; Calandro D; Hardikar AA; O'Neal DN; Fulcher G; Jenkins AJ BMJ Open; 2019 Dec; 9(12):e033059. PubMed ID: 31888933 [TBL] [Abstract][Full Text] [Related]
25. A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial. Heller S; White D; Lee E; Lawton J; Pollard D; Waugh N; Amiel S; Barnard K; Beckwith A; Brennan A; Campbell M; Cooper C; Dimairo M; Dixon S; Elliott J; Evans M; Green F; Hackney G; Hammond P; Hallowell N; Jaap A; Kennon B; Kirkham J; Lindsay R; Mansell P; Papaioannou D; Rankin D; Royle P; Smithson WH; Taylor C Health Technol Assess; 2017 Apr; 21(20):1-278. PubMed ID: 28440211 [TBL] [Abstract][Full Text] [Related]
26. Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry. Miller KM; Foster NC; Beck RW; Bergenstal RM; DuBose SN; DiMeglio LA; Maahs DM; Tamborlane WV; Diabetes Care; 2015 Jun; 38(6):971-8. PubMed ID: 25998289 [TBL] [Abstract][Full Text] [Related]
27. Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel study protocol. Bally L; Thabit H; Tauschmann M; Allen JM; Hartnell S; Wilinska ME; Exall J; Huegel V; Sibayan J; Borgman S; Cheng P; Blackburn M; Lawton J; Elleri D; Leelarathna L; Acerini CL; Campbell F; Shah VN; Criego A; Evans ML; Dunger DB; Kollman C; Bergenstal RM; Hovorka R BMJ Open; 2017 Jul; 7(7):e016738. PubMed ID: 28710224 [TBL] [Abstract][Full Text] [Related]
28. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion. Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D; Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572 [TBL] [Abstract][Full Text] [Related]
29. Expected Basal Insulin Requirement During Continuous Subcutaneous Insulin Infusion Therapy by Age Group, Sex, and Body Mass Index, Based on 25,718 Young People with Type 1 Diabetes in the DPV Registry. Biester T; Eckert A; Becker M; Boettcher C; Golembowski S; Heidtmann B; Klinkert C; Müther S; Rami-Merhar B; Holl RW Diabetes Technol Ther; 2023 Nov; 25(11):774-781. PubMed ID: 37668604 [No Abstract] [Full Text] [Related]
30. Type 1 diabetes in older adults: Comparing treatments and chronic complications in the United States T1D Exchange and the German/Austrian DPV registries. Weinstock RS; Schütz-Fuhrmann I; Connor CG; Hermann JM; Maahs DM; Schütt M; Agarwal S; Hofer SE; Beck RW; Holl RW; ; Diabetes Res Clin Pract; 2016 Dec; 122():28-37. PubMed ID: 27764721 [TBL] [Abstract][Full Text] [Related]
31. Type 1 diabetes during adolescence: International comparison between Germany, Austria, and Sweden. Hanberger L; Samuelsson U; Holl RW; Fröhlich-Reiterer E; Åkesson K; Hofer S Pediatr Diabetes; 2018 May; 19(3):506-511. PubMed ID: 28940551 [TBL] [Abstract][Full Text] [Related]
32. Insulin pump treatment; increasing prevalence, and predictors for better metabolic outcome in Danish children and adolescents with type 1 diabetes. Olsen B; Johannesen J; Fredheim S; Svensson J; Pediatr Diabetes; 2015 Jun; 16(4):256-62. PubMed ID: 25082292 [TBL] [Abstract][Full Text] [Related]
33. Mealtime insulin bolus adherence and glycemic control in adolescents on insulin pump therapy. Spaans E; van Hateren KJJ; Groenier KH; Bilo HJG; Kleefstra N; Brand PLP Eur J Pediatr; 2018 Dec; 177(12):1831-1836. PubMed ID: 30238153 [TBL] [Abstract][Full Text] [Related]
34. A Decade of Disparities in Diabetes Technology Use and HbA Addala A; Auzanneau M; Miller K; Maier W; Foster N; Kapellen T; Walker A; Rosenbauer J; Maahs DM; Holl RW Diabetes Care; 2021 Jan; 44(1):133-140. PubMed ID: 32938745 [TBL] [Abstract][Full Text] [Related]
35. A cohort of children with type 1 diabetes in Greece: predictors of direct costs of care. Karachaliou F; Athanasakis K; Tsentidis C; Soldatou A; Simatos G; Kyriopoulos J; Michalakos S; Karavanaki K Pediatr Diabetes; 2017 Aug; 18(5):405-412. PubMed ID: 27444352 [TBL] [Abstract][Full Text] [Related]
36. Effectiveness of Continuous Subcutaneous Insulin Infusion Pump Therapy During Five Years of Treatment on Metabolic Control in Children and Adolescents with Type 1 Diabetes Mellitus. Korkmaz Ö; Demir G; Çetin H; Mecidov İ; Atik Altınok Y; Özen S; Darcan Ş; Gökşen D J Clin Res Pediatr Endocrinol; 2018 Jun; 10(2):147-152. PubMed ID: 29537377 [TBL] [Abstract][Full Text] [Related]
37. Undertreatment of cardiovascular risk factors in the type 1 diabetes exchange clinic network (United States) and the prospective diabetes follow-up (Germany/Austria) registries. Shah VN; Grimsmann JM; Foster NC; Dost A; Miller KM; Pavel M; Weinstock RS; Karges W; Maahs DM; Holl RW Diabetes Obes Metab; 2020 Sep; 22(9):1577-1585. PubMed ID: 32329127 [TBL] [Abstract][Full Text] [Related]
38. Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes. Karges B; Schwandt A; Heidtmann B; Kordonouri O; Binder E; Schierloh U; Boettcher C; Kapellen T; Rosenbauer J; Holl RW JAMA; 2017 Oct; 318(14):1358-1366. PubMed ID: 29049584 [TBL] [Abstract][Full Text] [Related]
39. Treatment intensification without improved HbA1c levels in children and adolescents with Type 1 diabetes mellitus. Sildorf SM; Hertel NT; Thomsen J; Fredheim S; Hastrup H; Pipper C; Hertz B; Svensson J; Diabet Med; 2016 Apr; 33(4):515-22. PubMed ID: 26333180 [TBL] [Abstract][Full Text] [Related]
40. Comparing continuous subcutaneous insulin infusion and multiple daily injections in children with Type 1 diabetes in Sweden from 2011 to 2016-A longitudinal study from the Swedish National Quality Register (SWEDIABKIDS). Fureman AL; Lilja M; Lind T; Särnblad S; Bladh M; Samuelsson U Pediatr Diabetes; 2021 Aug; 22(5):766-775. PubMed ID: 33929074 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]